Open an account

Privia Health Group

PRVA · NASDAQ

$22.93+$0.49 (+2.18%)TodayMarket closed ·
Prev close $22.44

About PRVA

Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,226 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

Employees
1,226
Headquarters
Arlington, Virginia
Listed
Apr 29, 2021
Sector
Health Care
Industry
Health Care Providers & Services
Website
priviahealth.com

PRVA key statistics

Market cap
2.93B
Price-earnings ratio
106.86
Dividend yield
—
Average volume
1.32M
Volume
823.66K
Open price
$22.65
High today
$23.13
Low today
$22.60
52 Week high
$28.82
52 Week low
$18.92

Privia Health Group (PRVA) at a glance

Privia Health Group (PRVA) last traded at $22.93, with a market cap of 2.93B and a price-to-earnings ratio of 106.86.

Today the stock has traded between $22.60 and $23.13. The current price is 1.5% above the day's low and 0.9% below its high.

Volume so far is 823.66K shares, below the average of 1.32M shares a day.

Over the past year Privia Health Group has ranged from $18.92 to $28.82, and now sits 41% of the way up that range.

Privia Health Group met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.07 per share against an estimate of $0.0684.

The average analyst price target is $31.88, 39.0% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

90%of 10 analyst ratings say Buy
  • Buy90.0%
  • Hold10.0%
  • Sell0.0%
Price target · 19 analystsAvg $31.88
Low
$24.24
Now
$22.93
High
$42.00

PRVA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 49.2% on average.

  1. Q3 FY24: reported $0.03 per share against an estimate of $0.049
  2. Q4 FY24: reported $0.03 per share against an estimate of $0.0507
  3. Q1 FY25: reported $0.03 per share against an estimate of $0.0483
  4. Q2 FY25: reported $0.02 per share against an estimate of $0.0512
  5. Q3 FY25: reported $0.05 per share against an estimate of $0.0549
  6. Q4 FY25: reported $0.07 per share against an estimate of $0.0357
  7. Q1 FY26: reported $0.02 per share against an estimate of $0.0761
  8. Q2 FY26: reported $0.07 per share against an estimate of $0.0684

PRVA news

  • Press releaseGlobe Newswire

    Privia Health to Report Third Quarter 2026 Results on Thursday, November 5

  • Full Transcript: Privia Health Gr Q2 2026 Earnings Call

  • Press releaseGlobe Newswire

    Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

  • Press releaseGlobe Newswire

    Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

  • Press releaseGlobe Newswire

    Privia Health Reports First Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    Privia Health to Report First Quarter 2026 Results on Thursday, May 7

  • Press releaseBusiness Wire

    Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

  • Press releaseGlobe Newswire

    Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results

Similar companies

Companies in the same industry as Privia Health Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.